All News #Library
Others
Aviceda raises $207M for geographic atrophy drug`s ph. 3 journey
07 Jan 2025 //
FIERCE BIOTECH
Aviceda Announces Formation of Renowned European Clinical Advisory Board
08 Apr 2024 //
BUSINESSWIRE
Aviceda Completes Enrollment in Part 1 of SIGLEC Phase 2/3 U.S. Clinical Trial
23 Oct 2023 //
BUSINESSWIRE
Aviceda To Present at Major European Healthcare Conferences Highlighting AVD-104
25 Sep 2023 //
BUSINESSWIRE
Aviceda Therapeutics Appoints Biopharma and Business Senior Executive
16 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support